PBL Biomedical Laboratories, Inc.
Records under this name other than patents PBL Biomedical Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to PBL Biomedical Laboratories, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,666,995 | Interferons, uses and compositions related thereto Formerly held Lapsed on the fee record Ended Feb 23, 2014 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2014 | USPTO record |
| US 6,299,870 | Mutant human interferons Lapsed on the fee record Ended Oct 9, 2013 · USPTO record | Lapsed on the fee record | Ended Oct 9, 2013 | USPTO record |
| US 6,300,474 | Modified interferons Lapsed on the fee record Ended Oct 9, 2013 · USPTO record | Lapsed on the fee record | Ended Oct 9, 2013 | USPTO record |
| US 7,129,331 | Phosphorylated polypeptides and uses related thereto Lapsed on the fee record Ended Oct 31, 2010 · USPTO record | Lapsed on the fee record | Ended Oct 31, 2010 | USPTO record |
| US 6,225,455 | Constructs for producing phosphorylated fusion proteins Lapsed on the fee record Ended May 1, 2009 · USPTO record | Lapsed on the fee record | Ended May 1, 2009 | USPTO record |
| US 6,514,753 | Expression vectors for producing modified proteins Term ended Ended no later than Oct 28, 2008 · USPTO record | Term ended | Ended no later than Oct 28, 2008 | USPTO record |
| US 5,986,061 | Phosphorylated fusion proteins Term ended Term ended no later than Nov 16, 2019 · Low confidence | Term ended | Term ended no later than Nov 16, 2019 | Low confidence |
| US 6,001,589 | Method of identifying proteins modified by disease states related thereto Term ended Term ended no later than Dec 14, 2019 · Low confidence | Term ended | Term ended no later than Dec 14, 2019 | Low confidence |